Department of Psychiatry, SUNY Upstate Medical University, Syracuse, New York 13210, USA.
Subst Use Misuse. 2010 Mar;45(4):496-514. doi: 10.3109/10826080903452538.
Hepatitis C virus (HCV) knowledge, attitudes, beliefs, and experiences (KABE) of 64 HCV antibody positive methadone maintenance treatment (MMT) patients were assessed in conjunction with acceptability of an on-site semi-structured HCV education session, HCV RNA diagnostic testing, HCV treatment motivational assessment, and initiation of HCV treatment. The KABE interviews were conducted in 2006 and 2007 in an urban New York State MMT clinic in affiliation with a NIDA-funded HCV research project. The majority had basic knowledge of HCV disease, but poor understanding of HCV testing and treatment. While the majority of participants expressed fear of HCV treatment side effects, 88% accepted HCV RNA testing and 78% expressed willingness to start HCV treatment with the majority of chronically infected choosing to start HCV treatment medications. Study limitations and implications are discussed.
对 64 名 HCV 抗体阳性美沙酮维持治疗 (MMT) 患者的丙型肝炎病毒 (HCV) 知识、态度、信念和经验 (KABE) 进行了评估，并结合现场半结构化 HCV 教育课程、HCV RNA 诊断检测、HCV 治疗动机评估以及 HCV 治疗的启动的可接受性进行了评估。KABE 访谈于 2006 年至 2007 年在与美国国立卫生研究院资助的 HCV 研究项目有关联的纽约州一个城市 MMT 诊所进行。大多数人对 HCV 疾病有基本的了解，但对 HCV 检测和治疗的理解较差。尽管大多数参与者对 HCV 治疗的副作用表示恐惧，但 88%的人接受了 HCV RNA 检测，78%的人表示愿意开始 HCV 治疗，大多数慢性感染者选择开始 HCV 治疗药物。讨论了研究的局限性和意义。
